Transcellular fluid formation and vascular permeability increase by angiotensins.
D000804:Angiotensin II / Q000096:biosynthesis / Q000494:pharmacology*; D000818:Animals; D001202:Ascitic Fluid / Q000378:metabolism*; D001808:Blood Vessels / Q000187:drug effects*; D002199:Capillary Permeability / Q000187:drug effects*; D005260:Female; D006400:Hematocrit / Q000187:drug effects; D007668:Kidney / Q000378:metabolism*; D007672:Kidney Cortex / Q000378:metabolism; D009392:Nephrectomy; D009638:Norepinephrine / Q000494:pharmacology; D010996:Pleural Effusion / Q000378:metabolism*; D051381:Rats; D014667:Vasopressins / Q000494:pharmacology
D014667:Vasopressins; D000804:Angiotensin II; D009638:Norepinephrine